Chardan Healthcare Acquisition 2 Corp. (CHAQ) Shareholders Approve Renovacor Deal

Chardan Healthcare Acquisition 2 Corp. (NYSE:CHAQ) announced in a press release today that its shareholders have approved its combination with biotech firm Renovacor in a meeting held earlier this morning. CHAQ did not report exact redemption amounts, but mentioned the transaction will provide gross proceeds of approximately $95.1 million, including $30.0 million from the concurrent closing
Read More